Takeda Pharmaceutical Company Limited TKPHF
OTC PK
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 1.21B | 710.50M | -2.35B | 672.49M | -80.03M |
| Total Depreciation and Amortization | 1.03B | 1.02B | 773.16M | 1.24B | 1.25B |
| Total Amortization of Deferred Charges | -- | -- | 271.12M | -- | -- |
| Total Other Non-Cash Items | -404.05M | 206.85M | 179.26M | 767.64M | 1.24B |
| Change in Net Operating Assets | 73.46M | -1.14B | 1.60B | -255.21M | 148.76M |
| Cash from Operations | 1.91B | 801.05M | 474.94M | 2.42B | 2.56B |
| Capital Expenditure | -280.91M | -337.76M | -295.45M | -270.14M | -271.88M |
| Sale of Property, Plant, and Equipment | 2.28M | 6.88M | 344.10K | 97.30K | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 77.15M | 65.67M | 3.28M | 20.54M | 2.40M |
| Other Investing Activities | 69.03M | -285.28M | -77.90M | -1.24B | -56.91M |
| Cash from Investing | -132.45M | -550.49M | -369.72M | -1.49B | -326.39M |
| Total Debt Issued | -- | -- | 60.00B | 0.00 | 342.51B |
| Total Debt Repaid | -250.02B | -11.29B | -85.62B | -9.89B | -305.95B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 0.00 | -1.01B | 0.00 | 0.00 | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -48.61M | -942.33M | -56.00M | -967.03M | -59.58M |
| Other Financing Activities | -53.27B | -17.92B | -43.09B | -33.53B | -39.75B |
| Cash from Financing | -1.95B | -1.13B | -493.82M | -1.25B | -81.24M |
| Foreign Exchange rate Adjustments | -91.91M | 39.89M | 7.00M | 145.63M | 90.62M |
| Miscellaneous Cash Flow Adjustments | -6.30K | 6.30K | -6.40K | -- | -- |
| Net Change in Cash | -266.82M | -841.53M | -381.61M | -172.27M | 2.25B |